Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:48 PM
Ignite Modification Date:
2025-12-24 @ 1:48 PM
NCT ID:
NCT00819195
Eligibility Criteria:
Inclusion Criteria:
* Relapsing-remitting (RR) MS patients (McDonald criteria)
* Ages 18-55
* Males and females
* EDSS score ≤5
* No prior treatment with Copaxone
* Prior treatment with corticosteroids or interferon-beta (-1a or -1b) is acceptable, provided there is a washout period of at least one month
Exclusion Criteria:
* Treatment with Tysabri, Novantrone or cyclophosphamide
* Treatment with other immunomodulatory therapies (e.g. imuran, mycophenolate or methotrexate)
* Primary-progressive (PP) and secondary-progressive (SP) multiple sclerosis
* Pregnancy
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT00819195
Study Brief:
Protocol Section:
NCT00819195